DNA · Ginkgo Bioworks Holdings Inc
United States · RS rating 92 · As of 2026-10-14
| Price | 11.53 USD |
|---|---|
| 1-day change | -2.0% |
| RS rating (overall / 1M / 3M / 12M) | 92 / 98 / 95 / 31 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 44 / 43 / 67 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +46.0% |
| Sales growth Q/Q | -14.0% |
| Distance from 52-week high | +27.2% |
| Market cap (USD) | $476.8M |